Feng Lin

Part of Suzhou Tongxin Medical Equipment Co. Ltd., CH Biomedical (USA), Inc. focuses on the research and development of ventricular assist devices (VADs) to benefit patients with end-stage heart failure. The company is based in Torrance, CA. The company's implantable CH-VAD® left ventricular assist system (LVAS) is a new generation of totally magnetically levitated VAD. The company was founded in 2009. The CEO is Feng Lin.

Suzhou Tongxin Medical Equipment Co. Ltd. specializes in the development of medical equipment. The company is based in Suzhou, CN. The Chinese company's flagship product is the CiFux implantable left ventricular assist system, which is a next-generation fully magnetically levitated artificial heart. The system uses a rotating blade rotor to create negative pressure in the blood pump rotor center, pumping the patient's left ventricular blood to the ascending aorta, generating flow in the circulatory system, and achieving collaborative work between the blood pump and the natural heart. and has subsidiaries in the United States. The company was founded in 2008 by Chen Chen, Feng Lin, Chen Chen. Chen Chen has been the CEO since 2008.